Evaluation of the pharmacokinetics of Atripla with and without food in HIV-1 infected Ugandan adults.
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2016
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 14 Mar 2012 Planned patient number is 15, actual initiation date (Dec 2009) added and additional lead trial investigator (Dr Concepta Merry) identified as reported by Pan-African Clinical Trials Registry record.
- 14 Mar 2012 Planned end date (Feb 2010) added as reported by Pan-African Clinical Trials Registry record.
- 17 Sep 2011 New trial record